ONTOLOGY REPORT - ANNOTATIONS
| Term: | Lung Diseases |
|
| Accession: | RDO:0001799
|
browse the term
|
| Definition: | Pathological processes involving any part of the LUNG. |
| Synonyms: | exact_synonym: | Lung Disease; Pulmonary Disease; Pulmonary Diseases |
| | primary_id: | MESH:D008171 |
|
|
Lung Diseases
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
IPM |
10 |
95,361,338 |
95,381,455 |
RGD:2325231 |
RGD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
IEP |
10 |
95,361,338 |
95,381,455 |
RGD:4140485 |
RGD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
ISS |
10 |
95,361,338 |
95,381,455 |
RGD:4140488 |
RGD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
ISS |
10 |
95,361,338 |
95,381,455 |
RGD:5129168 |
RGD |
| G |
Ace2 |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
|
|
IEP |
X |
51,051,758 |
51,096,036 |
RGD:4140485 |
RGD |
| G |
Ada |
adenosine deaminase |
|
|
IEP |
3 |
154,636,530 |
154,660,637 |
RGD:5128845 |
RGD |
| G |
Adora1 |
adenosine A1 receptor |
|
|
IED |
13 |
47,160,292 |
47,192,804 |
RGD:5129095 |
RGD |
| G |
Adora1 |
adenosine A1 receptor |
|
|
ISS |
13 |
47,160,292 |
47,192,804 |
RGD:5129093 |
RGD |
| G |
Adora2a |
adenosine A2a receptor |
|
|
IED |
20 |
13,815,719 |
13,834,131 |
RGD:4890363 |
RGD |
| G |
Adora2a |
adenosine A2a receptor |
|
|
IED |
20 |
13,815,719 |
13,834,131 |
RGD:4890383 |
RGD |
| G |
Adora2a |
adenosine A2a receptor |
|
|
ISS |
20 |
13,815,719 |
13,834,131 |
RGD:4890370 |
RGD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
|
ISS |
17 |
40,629,318 |
40,684,982 |
RGD:5129168 |
RGD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
|
ISS |
4 |
152,610,283 |
152,657,891 |
RGD:4890417 |
RGD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
|
ISS |
4 |
152,610,283 |
152,657,891 |
RGD:4890414 |
RGD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
|
IEP |
15 |
26,904,124 |
26,906,224 |
RGD:2315673 |
RGD |
| G |
Bdkrb2 |
bradykinin receptor B2 |
|
|
IPM |
6 |
129,744,781 |
129,748,851 |
RGD:4890457 |
RGD |
| G |
C3 |
complement component 3 |
|
|
ISS |
|
|
|
RGD:5129564 |
RGD |
| G |
C3ar1 |
complement component 3a receptor 1 |
|
|
ISS |
4 |
159,326,402 |
159,333,433 |
RGD:5129564 |
RGD |
| G |
C3ar1 |
complement component 3a receptor 1 |
|
|
IEP |
4 |
159,326,402 |
159,333,433 |
RGD:5129560 |
RGD |
| G |
C5 |
complement component 5 |
|
|
ISS |
3 |
14,011,115 |
14,102,744 |
RGD:5130168 |
RGD |
| G |
C5 |
complement component 5 |
|
|
ISS |
3 |
14,011,115 |
14,102,744 |
RGD:5130154 |
RGD |
| G |
C5ar1 |
complement component 5a receptor 1 |
|
|
ISS |
|
|
|
RGD:5130168 |
RGD |
| G |
C5ar1 |
complement component 5a receptor 1 |
|
|
ISS |
|
|
|
RGD:5129564 |
RGD |
| G |
C5ar1 |
complement component 5a receptor 1 |
|
|
IEP |
|
|
|
RGD:5129560 |
RGD |
| G |
Casp1 |
caspase 1 |
|
|
ISS |
8 |
2,027,976 |
2,036,872 |
RGD:5130182 |
RGD |
| G |
Casp1 |
caspase 1 |
|
|
ISS |
8 |
2,027,976 |
2,036,872 |
RGD:4889574 |
RGD |
| G |
Cat |
catalase |
|
|
ISS |
3 |
88,654,077 |
88,686,212 |
RGD:5130768 |
RGD |
| G |
Cat |
catalase |
|
|
ISS |
3 |
88,654,077 |
88,686,212 |
RGD:5130199 |
RGD |
| G |
Cat |
catalase |
|
|
IED |
3 |
88,654,077 |
88,686,212 |
RGD:5130773 |
RGD |
| G |
Cat |
catalase |
|
|
ISS |
3 |
88,654,077 |
88,686,212 |
RGD:5130745 |
RGD |
| G |
Cat |
catalase |
|
|
IEP |
3 |
88,654,077 |
88,686,212 |
RGD:5130747 |
RGD |
| G |
Cat |
catalase |
|
|
IED |
3 |
88,654,077 |
88,686,212 |
RGD:5130202 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
IEP |
10 |
70,256,263 |
70,258,061 |
RGD:4891456 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
IEP |
10 |
70,256,263 |
70,258,061 |
RGD:2307141 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
IEP |
10 |
71,605,791 |
71,610,330 |
RGD:2307141 |
RGD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
|
ISS |
8 |
128,892,784 |
128,893,905 |
RGD:4145002 |
RGD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
|
ISS |
8 |
128,892,784 |
128,893,905 |
RGD:4144897 |
RGD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
|
ISS |
8 |
128,892,784 |
128,893,905 |
RGD:4144896 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
|
ISS |
18 |
29,374,593 |
29,376,190 |
RGD:4144789 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
|
ISS |
18 |
29,374,593 |
29,376,190 |
RGD:4144143 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
|
ISS |
18 |
29,374,593 |
29,376,190 |
RGD:4144782 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140445 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Severity |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140397 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Severity |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140441 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Onset |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140448 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Severity |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140446 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Disease_progression |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140390 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140453 |
RGD |
| G |
Chi3l1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
|
|
ISS |
13 |
47,139,658 |
47,147,591 |
RGD:4892651 |
RGD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
|
ISS |
10 |
87,473,990 |
87,476,365 |
RGD:5133732 |
RGD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
|
IEP |
10 |
87,473,990 |
87,476,365 |
RGD:5133737 |
RGD |
| G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
|
ISS |
9 |
59,495,773 |
59,501,300 |
RGD:4891507 |
RGD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
|
IEP |
19 |
10,666,940 |
10,676,424 |
RGD:4891892 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
ISS |
14 |
18,690,339 |
18,692,118 |
RGD:5135060 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
ISS |
14 |
18,690,339 |
18,692,118 |
RGD:4891479 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
ISS |
14 |
18,690,339 |
18,692,118 |
RGD:5134979 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
IEP |
14 |
18,690,339 |
18,692,118 |
RGD:5134956 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
IEP |
14 |
18,690,339 |
18,692,118 |
RGD:5134960 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
IEP |
14 |
18,690,339 |
18,692,118 |
RGD:4891456 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
ISS |
14 |
18,690,339 |
18,692,118 |
RGD:5134978 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
IEP |
14 |
18,690,339 |
18,692,118 |
RGD:5134961 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
ISS |
14 |
18,677,129 |
18,679,175 |
RGD:5135056 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
ISS |
14 |
18,677,129 |
18,679,175 |
RGD:5135024 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
IEP |
14 |
18,677,129 |
18,679,175 |
RGD:5134960 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
IEP |
14 |
18,677,129 |
18,679,175 |
RGD:4891456 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
ISS |
14 |
18,677,129 |
18,679,175 |
RGD:4891479 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
IEP |
14 |
18,677,129 |
18,679,175 |
RGD:5134961 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
ISS |
14 |
18,677,129 |
18,679,175 |
RGD:5135060 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
IEP |
14 |
18,677,129 |
18,679,175 |
RGD:5135023 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
IEP |
14 |
18,677,129 |
18,679,175 |
RGD:5135036 |
RGD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
|
ISS |
9 |
73,470,943 |
73,477,315 |
RGD:5134955 |
RGD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
|
ISS |
1 |
200,918,521 |
200,928,919 |
RGD:4892222 |
RGD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
|
ISS |
X |
94,802,078 |
94,803,097 |
RGD:4888512 |
RGD |
| G |
Defb1 |
defensin beta 1 |
|
Severity |
ISS |
16 |
74,980,054 |
74,995,445 |
RGD:4892247 |
RGD |
| G |
Defb1 |
defensin beta 1 |
|
Disease_progression |
ISS |
16 |
74,980,054 |
74,995,445 |
RGD:4892259 |
RGD |
| G |
Defb4 |
defensin beta 4 |
|
|
ISS |
16 |
75,442,005 |
75,445,196 |
RGD:4892267 |
RGD |
| G |
Ednra |
endothelin receptor type A |
|
Severity |
ISS |
19 |
32,042,366 |
32,108,153 |
RGD:4892286 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
IEP |
14 |
97,617,358 |
97,788,211 |
RGD:1578630 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5131862 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
ISS |
18 |
27,343,919 |
27,346,117 |
RGD:5131881 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
ISS |
18 |
27,343,919 |
27,346,117 |
RGD:5131893 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
IEP |
18 |
27,343,919 |
27,346,117 |
RGD:5131898 |
RGD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
|
IEP |
2 |
25,886,177 |
25,899,128 |
RGD:4892587 |
RGD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
|
IEP |
10 |
40,311,094 |
40,319,382 |
RGD:2312626 |
RGD |
| G |
Gsn |
gelsolin |
|
|
IEP |
3 |
14,360,245 |
14,386,313 |
RGD:1599873 |
RGD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
Susceptibility |
ISS |
2 |
203,575,444 |
203,580,821 |
RGD:4142512 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
|
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:4140945 |
RGD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
|
ISS |
20 |
13,604,355 |
13,621,456 |
RGD:5490587 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:4143390 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:4145326 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
IEP |
19 |
13,963,139 |
13,969,960 |
RGD:4140396 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:4145370 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
IED |
19 |
13,963,139 |
13,969,960 |
RGD:4145350 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
IED |
19 |
13,963,139 |
13,969,960 |
RGD:4145327 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
IPM |
19 |
13,963,139 |
13,969,960 |
RGD:4145326 |
RGD |
| G |
Il10 |
interleukin 10 |
|
|
IED |
13 |
43,953,900 |
43,957,766 |
RGD:2311048 |
RGD |
| G |
Il10 |
interleukin 10 |
|
|
IEP |
13 |
43,953,900 |
43,957,766 |
RGD:4140398 |
RGD |
| G |
Il10 |
interleukin 10 |
|
|
IEP |
13 |
43,953,900 |
43,957,766 |
RGD:4140396 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
IEP |
10 |
39,093,512 |
39,096,069 |
RGD:4145512 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:4145647 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:4145526 |
RGD |
| G |
Il15 |
interleukin 15 |
|
|
ISS |
19 |
27,487,268 |
27,498,973 |
RGD:4974390 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889576 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889574 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889574 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889548 |
RGD |
| G |
Il18r1 |
interleukin 18 receptor 1 |
|
|
ISS |
9 |
39,627,915 |
39,659,828 |
RGD:4889574 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
|
ISS |
3 |
116,913,612 |
116,924,114 |
RGD:4142805 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
|
ISS |
3 |
116,913,612 |
116,924,114 |
RGD:4142811 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
|
ISS |
3 |
116,913,612 |
116,924,114 |
RGD:4142809 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IEP |
3 |
116,964,422 |
116,970,867 |
RGD:4142815 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
Susceptibility |
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4142870 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4142814 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IEP |
3 |
116,964,422 |
116,970,867 |
RGD:4142810 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IEP |
3 |
116,964,422 |
116,970,867 |
RGD:4142819 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4143189 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
IED |
3 |
2,607,800 |
2,613,216 |
RGD:2311107 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
IEP |
3 |
2,607,800 |
2,613,216 |
RGD:4143168 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
IPM |
3 |
2,607,800 |
2,613,216 |
RGD:4143193 |
RGD |
| G |
Il4r |
interleukin 4 receptor |
|
|
ISS |
1 |
184,612,903 |
184,637,863 |
RGD:4889995 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
IED |
4 |
456,799 |
461,376 |
RGD:5134961 |
RGD |
| G |
Il6 |
interleukin 6 |
|
Severity |
IEP |
4 |
456,799 |
461,376 |
RGD:4143244 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:5128667 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:4143242 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:4143256 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:4143249 |
RGD |
| G |
Il9 |
interleukin 9 |
|
|
ISS |
17 |
14,068,757 |
14,071,880 |
RGD:5128689 |
RGD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
|
IEP |
10 |
39,220,600 |
39,227,602 |
RGD:5128716 |
RGD |
| G |
Itgb3 |
integrin, beta 3 |
|
|
ISS |
|
|
|
RGD:5037229 |
RGD |
| G |
Lep |
leptin |
|
|
ISS |
4 |
55,943,837 |
55,945,938 |
RGD:5128844 |
RGD |
| G |
Mefv |
Mediterranean fever |
|
|
ISS |
10 |
12,059,821 |
12,069,345 |
RGD:5129189 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISS |
20 |
13,191,986 |
13,192,851 |
RGD:4891012 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
IPM |
20 |
13,191,986 |
13,192,851 |
RGD:4891023 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISS |
20 |
13,191,986 |
13,192,851 |
RGD:4891017 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISS |
20 |
13,191,986 |
13,192,851 |
RGD:4891012 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5129490 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
IPM |
3 |
155,985,473 |
155,993,433 |
RGD:5129531 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
IPM |
3 |
155,985,473 |
155,993,433 |
RGD:5129548 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5130156 |
RGD |
| G |
Mpo |
myeloperoxidase |
|
|
ISS |
10 |
76,085,872 |
76,097,012 |
RGD:5130962 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
Severity |
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:5131182 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:5131175 |
RGD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
|
ISS |
3 |
58,366,693 |
58,394,116 |
RGD:5134977 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:4891432 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:4891457 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:4891454 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:4891426 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IPM |
10 |
65,036,884 |
65,072,453 |
RGD:4891465 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:4892013 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IEP |
4 |
6,158,847 |
6,179,441 |
RGD:4892011 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:4891426 |
RGD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
Susceptibility |
ISS |
19 |
37,251,147 |
37,266,040 |
RGD:5134962 |
RGD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
Disease_progression |
ISS |
18 |
32,371,496 |
32,459,145 |
RGD:4892330 |
RGD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
|
IEP |
18 |
32,371,496 |
32,459,145 |
RGD:4892201 |
RGD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
|
ISS |
12 |
20,931,996 |
20,942,374 |
RGD:4143514 |
RGD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
Severity |
ISS |
12 |
20,931,996 |
20,942,374 |
RGD:4144040 |
RGD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
|
ISS |
12 |
20,931,996 |
20,942,374 |
RGD:4143512 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143448 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143451 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
IEP |
16 |
17,570,887 |
17,574,389 |
RGD:4143505 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4144871 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
IEP |
16 |
17,570,887 |
17,574,389 |
RGD:4143446 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
IEP |
4 |
105,609,410 |
105,618,452 |
RGD:4143287 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143390 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143392 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143451 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
IEP |
4 |
105,609,410 |
105,618,452 |
RGD:4143446 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143463 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:4144117 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:1624153 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:4143420 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:4143451 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143503 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143256 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
Disease_progression |
ISS |
|
|
|
RGD:4143488 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
IEP |
|
|
|
RGD:4143505 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:4145276 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
Severity |
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:4144796 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
IEP |
1 |
80,894,705 |
80,911,020 |
RGD:4145127 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
IEP |
1 |
80,894,705 |
80,911,020 |
RGD:4145122 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
IED |
2 |
175,607,990 |
175,613,992 |
RGD:2312725 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
IEP |
2 |
175,607,990 |
175,613,992 |
RGD:4145321 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:4145340 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
IEP |
2 |
175,607,990 |
175,613,992 |
RGD:4145303 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
IED |
5 |
83,564,100 |
83,577,735 |
RGD:2312725 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144143 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4143249 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144149 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
IEP |
5 |
83,564,100 |
83,577,735 |
RGD:4144082 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144789 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
IEP |
5 |
83,564,100 |
83,577,735 |
RGD:5128779 |
RGD |
| G |
Tnc |
tenascin C |
|
|
ISS |
|
|
|
RGD:4889561 |
RGD |
| G |
Tnc |
tenascin C |
|
|
ISS |
|
|
|
RGD:4889568 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
IEP |
20 |
3,661,000 |
3,663,618 |
RGD:4145512 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4143432 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4142805 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4142809 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
IEP |
20 |
3,661,000 |
3,663,618 |
RGD:4143425 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
IEP |
20 |
3,661,000 |
3,663,618 |
RGD:4143427 |
RGD |
Adenocarcinoma of lung
|
| G |
Myc |
myelocytomatosis oncogene |
|
|
ISS |
7 |
98,953,142 |
98,958,060 |
RGD:7207787 |
RGD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
|
ISS |
6 |
128,461,775 |
128,469,309 |
RGD:5147446 |
RGD |
Adenocarcinoma, Bronchiolo-Alveolar
|
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5131630 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5131465 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
ISS |
18 |
27,343,919 |
27,346,117 |
RGD:5131942 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
|
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:4140940 |
RGD |
alpha 1-Antitrypsin Deficiency
|
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
|
ISS |
6 |
127,998,617 |
128,021,719 |
RGD:7240710 |
OMIM |
Alveolar capillary dysplasia
|
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
|
ISS |
9 |
65,907,211 |
66,017,942 |
RGD:7240710 |
OMIM |
Aspergillosis, Allergic Bronchopulmonary
|
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
|
ISS |
19 |
10,641,376 |
10,642,827 |
RGD:4145612 |
RGD |
| G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
|
ISS |
8 |
128,693,658 |
128,699,213 |
RGD:5688155 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140482 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
|
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889577 |
RGD |
| G |
Tlr9 |
toll-like receptor 9 |
|
Susceptibility |
ISS |
|
|
|
RGD:5130863 |
RGD |
| G |
Tlr9 |
toll-like receptor 9 |
|
|
ISS |
|
|
|
RGD:5130858 |
RGD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
Susceptibility |
ISS |
4 |
162,172,563 |
162,185,252 |
RGD:5131174 |
RGD |
Bronchial Neoplasms
|
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:4145523 |
RGD |
Bronchopneumonia
|
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:4892019 |
RGD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
Disease_progression |
ISS |
9 |
73,470,943 |
73,477,315 |
RGD:5134954 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
|
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889483 |
RGD |
Carcinoma, Bronchogenic
|
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
|
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:4142527 |
RGD |
| G |
Il10 |
interleukin 10 |
|
|
ISS |
13 |
43,953,900 |
43,957,766 |
RGD:4143231 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143231 |
RGD |
Carcinoma, Large Cell
|
| G |
Met |
met proto-oncogene |
|
Severity |
ISS |
4 |
43,134,183 |
43,211,355 |
RGD:2317441 |
RGD |
| G |
Prkca |
protein kinase C, alpha |
|
|
ISS |
10 |
97,367,196 |
97,638,910 |
RGD:2292463 |
RGD |
| G |
Strap |
serine/threonine kinase receptor associated protein |
|
|
ISS |
4 |
174,863,502 |
174,877,750 |
RGD:1581429 |
RGD |
Carcinoma, Non-Small-Cell Lung
|
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
|
ISS |
20 |
4,250,613 |
4,253,540 |
RGD:7245515 |
RGD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISS |
6 |
137,640,482 |
137,657,552 |
RGD:5133243 |
RGD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
|
ISS |
4 |
67,117,759 |
67,243,058 |
RGD:5133243 |
RGD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
|
ISS |
4 |
67,117,759 |
67,243,058 |
RGD:5133242 |
RGD |
| G |
Cda |
cytidine deaminase |
|
|
ISS |
5 |
157,117,303 |
157,143,989 |
RGD:2316365 |
RGD |
| G |
Cdh13 |
cadherin 13 |
|
|
ISS |
19 |
48,507,173 |
49,575,123 |
RGD:2293545 |
RGD |
| G |
Chi3l1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
|
Severity |
ISS |
13 |
47,139,658 |
47,147,591 |
RGD:4892660 |
RGD |
| G |
Cmpk1 |
cytidine monophosphate (UMP-CMP) kinase 1 |
|
Severity |
ISS |
5 |
135,320,845 |
135,348,973 |
RGD:5133252 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5133241 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5131629 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5133242 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:1601010 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
Susceptibility |
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5131640 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
Resistance |
ISS |
18 |
27,343,919 |
27,346,117 |
RGD:5131925 |
RGD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
Disease_progression |
ISS |
13 |
96,722,973 |
96,752,940 |
RGD:4889124 |
RGD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
|
ISS |
10 |
87,219,157 |
87,242,919 |
RGD:5133243 |
RGD |
| G |
Esr1 |
estrogen receptor 1 |
|
|
ISS |
1 |
35,523,680 |
35,759,891 |
RGD:4892255 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
Susceptibility |
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:4140944 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
|
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:4140950 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
Disease_progression |
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:4145465 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889836 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
|
ISS |
3 |
116,913,612 |
116,924,114 |
RGD:4142793 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
Susceptibility |
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4143167 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
Susceptibility |
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143167 |
RGD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
|
ISS |
10 |
39,220,600 |
39,227,602 |
RGD:1600014 |
RGD |
| G |
Itgb3 |
integrin, beta 3 |
|
|
ISS |
|
|
|
RGD:5037228 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:5133242 |
RGD |
| G |
Lep |
leptin |
|
|
ISS |
4 |
55,943,837 |
55,945,938 |
RGD:5128815 |
RGD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
|
ISS |
20 |
3,657,842 |
3,659,848 |
RGD:4143264 |
RGD |
| G |
Ltf |
lactotransferrin |
|
|
ISS |
8 |
115,417,764 |
115,440,609 |
RGD:7243860 |
RGD |
| G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
|
Susceptibility |
ISS |
8 |
112,111,358 |
112,113,311 |
RGD:1599219 |
RGD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
ISS |
8 |
68,379,074 |
68,451,554 |
RGD:5133243 |
RGD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
ISS |
8 |
68,379,074 |
68,451,554 |
RGD:5133242 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
4 |
43,134,183 |
43,211,355 |
RGD:5133242 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
4 |
43,134,183 |
43,211,355 |
RGD:5133241 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
ISS |
4 |
43,134,183 |
43,211,355 |
RGD:5133243 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISS |
20 |
13,191,986 |
13,192,851 |
RGD:4891022 |
RGD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
|
ISS |
8 |
4,526,018 |
4,533,730 |
RGD:5129528 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
Disease_progression |
IEP |
3 |
155,985,473 |
155,993,433 |
RGD:5129215 |
RGD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
Susceptibility |
ISS |
16 |
23,855,555 |
23,876,531 |
RGD:4140950 |
RGD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
Disease_progression |
ISS |
19 |
37,251,147 |
37,266,040 |
RGD:5133265 |
RGD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
|
ISS |
19 |
37,251,147 |
37,266,040 |
RGD:5133268 |
RGD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
|
ISS |
2 |
118,640,277 |
118,672,440 |
RGD:5133243 |
RGD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
|
ISS |
2 |
118,640,277 |
118,672,440 |
RGD:5133242 |
RGD |
| G |
Plau |
plasminogen activator, urokinase |
|
|
ISS |
15 |
3,680,072 |
3,686,232 |
RGD:4892055 |
RGD |
| G |
Pten |
phosphatase and tensin homolog |
|
|
ISS |
1 |
236,771,027 |
236,837,261 |
RGD:5133242 |
RGD |
| G |
Ptges |
prostaglandin E synthase |
|
Severity |
ISS |
3 |
9,946,194 |
9,957,538 |
RGD:5135302 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
Severity |
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:5135471 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
Severity |
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:5135302 |
RGD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
|
ISS |
1 |
208,262,669 |
208,273,148 |
RGD:2298765 |
RGD |
| G |
Robo1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
|
|
IEP |
11 |
10,784,947 |
11,720,646 |
RGD:2314868 |
RGD |
| G |
Scgb3a2 |
secretoglobin, family 3A, member 2 |
|
|
ISS |
18 |
37,200,474 |
37,203,396 |
RGD:5147390 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
Disease_progression |
ISS |
|
|
|
RGD:4143490 |
RGD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
|
ISS |
|
|
|
RGD:1581361 |
RGD |
| G |
Thbd |
thrombomodulin |
|
Disease_progression |
ISS |
3 |
137,158,955 |
137,162,607 |
RGD:5685035 |
RGD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
|
ISS |
|
|
|
RGD:2317237 |
RGD |
| G |
Tlr9 |
toll-like receptor 9 |
|
|
ISS |
|
|
|
RGD:5130185 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4142793 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4143264 |
RGD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
Severity |
ISS |
4 |
162,172,563 |
162,185,252 |
RGD:5131202 |
RGD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
Disease_progression |
ISS |
4 |
162,172,563 |
162,185,252 |
RGD:5131156 |
RGD |
| G |
Tp53 |
tumor protein p53 |
|
|
ISS |
10 |
56,399,721 |
56,411,150 |
RGD:5133242 |
RGD |
| G |
Tymp |
thymidine phosphorylase |
|
|
ISS |
7 |
127,666,518 |
127,671,624 |
RGD:2325156 |
RGD |
Carrington syndrome
|
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
|
ISS |
14 |
17,265,986 |
17,268,183 |
RGD:5135443 |
RGD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
|
ISS |
14 |
17,284,085 |
17,288,996 |
RGD:5135443 |
RGD |
Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress
|
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
|
ISS |
6 |
76,916,943 |
76,920,133 |
RGD:7240710 |
OMIM |
| G |
Ttf1 |
transcription termination factor, RNA polymerase I |
|
|
ISS |
3 |
8,067,017 |
8,086,185 |
RGD:7240710 |
OMIM |
Cystic Fibrosis
|
| G |
Adrb1 |
adrenoceptor beta 1 |
|
|
ISS |
1 |
263,025,655 |
263,027,055 |
RGD:5129107 |
RGD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
|
ISS |
18 |
58,174,958 |
58,177,000 |
RGD:5129107 |
RGD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
|
ISS |
10 |
70,279,161 |
70,283,762 |
RGD:4145455 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:4143275 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140440 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140481 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:734772 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140442 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
|
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140464 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Severity |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140401 |
RGD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
Severity |
ISS |
4 |
43,874,852 |
44,041,870 |
RGD:4140439 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
ISS |
14 |
18,690,339 |
18,692,118 |
RGD:5135456 |
RGD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
|
ISS |
14 |
17,284,085 |
17,288,996 |
RGD:5135456 |
RGD |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
|
ISS |
9 |
73,470,943 |
73,477,315 |
RGD:5135034 |
RGD |
| G |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
|
|
ISS |
X |
89,794,276 |
89,796,927 |
RGD:4145632 |
RGD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
Severity |
ISS |
8 |
61,462,207 |
61,468,237 |
RGD:4889126 |
RGD |
| G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
|
|
ISS |
10 |
31,585,703 |
31,610,825 |
RGD:5135530 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:4145410 |
RGD |
| G |
Il17a |
interleukin 17A |
|
|
ISS |
9 |
19,454,979 |
19,458,467 |
RGD:4889105 |
RGD |
| G |
Il17a |
interleukin 17A |
|
|
ISS |
9 |
19,454,979 |
19,458,467 |
RGD:4889130 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889551 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
Severity |
ISS |
3 |
116,913,612 |
116,924,114 |
RGD:4142849 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
Severity |
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4142844 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4143181 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:4143275 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
Severity |
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889443 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
Severity |
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889447 |
RGD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
Disease_progression |
ISS |
12 |
39,812,500 |
39,869,484 |
RGD:5132627 |
RGD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
|
ISS |
12 |
39,812,500 |
39,869,484 |
RGD:5132865 |
RGD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
|
ISS |
12 |
39,812,500 |
39,869,484 |
RGD:5132868 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:4891958 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:4892049 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:5135298 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:5135523 |
RGD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
ISS |
20 |
1,412,553 |
1,416,692 |
RGD:5144066 |
RGD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
Severity |
ISS |
6 |
128,461,775 |
128,469,309 |
RGD:5147439 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143403 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:4143403 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143502 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
Severity |
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144179 |
RGD |
Hyaline Membrane Disease
|
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
|
ISS |
12 |
20,931,996 |
20,942,374 |
RGD:4144850 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:4143444 |
RGD |
Hypertension, Pulmonary
|
| G |
Acvrl1 |
activin A receptor type II-like 1 |
|
Disease_progression |
ISS |
7 |
139,873,596 |
139,884,675 |
RGD:5128837 |
RGD |
| G |
Acvrl1 |
activin A receptor type II-like 1 |
|
|
IEP |
7 |
139,873,596 |
139,884,675 |
RGD:1601116 |
RGD |
| G |
Acvrl1 |
activin A receptor type II-like 1 |
|
Susceptibility |
ISS |
7 |
139,873,596 |
139,884,675 |
RGD:1601117 |
RGD |
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
|
ISS |
2 |
235,979,108 |
235,991,515 |
RGD:5128886 |
RGD |
| G |
Adm |
adrenomedullin |
|
|
ISS |
1 |
168,380,255 |
168,382,426 |
RGD:1625305 |
RGD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
|
IEP |
20 |
4,250,613 |
4,253,540 |
RGD:7244258 |
RGD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
|
IPM |
20 |
4,250,613 |
4,253,540 |
RGD:7244258 |
RGD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
|
ISS |
20 |
4,250,613 |
4,253,540 |
RGD:7244258 |
RGD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
|
IED |
19 |
54,738,556 |
54,750,349 |
RGD:5129162 |
RGD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
Onset |
ISS |
17 |
40,629,318 |
40,684,982 |
RGD:5147450 |
RGD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
|
IEP |
|
|
|
RGD:4144185 |
RGD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
|
IED |
4 |
152,610,283 |
152,657,891 |
RGD:734558 |
RGD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
|
ISS |
4 |
152,610,283 |
152,657,891 |
RGD:1626154 |
RGD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
|
IPM |
4 |
152,610,283 |
152,657,891 |
RGD:4890418 |
RGD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
|
ISS |
12 |
6,245,808 |
6,269,796 |
RGD:1626154 |
RGD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
|
IPM |
12 |
6,245,808 |
6,269,796 |
RGD:734558 |
RGD |
| G |
Angpt1 |
angiopoietin 1 |
|
|
IED |
7 |
78,195,504 |
78,451,471 |
RGD:1578336 |
RGD |
| G |
Angpt1 |
angiopoietin 1 |
|
|
IEP |
7 |
78,195,504 |
78,451,471 |
RGD:2316069 |
RGD |
| G |
Angpt2 |
angiopoietin 2 |
|
|
IEP |
16 |
75,891,757 |
75,942,255 |
RGD:2314185 |
RGD |
| G |
Apln |
apelin |
|
|
ISS |
X |
134,387,285 |
134,396,762 |
RGD:1626175 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
IEP |
13 |
12,730,736 |
12,905,108 |
RGD:2293022 |
RGD |
| G |
Bdkrb2 |
bradykinin receptor B2 |
|
|
IED |
6 |
129,744,781 |
129,748,851 |
RGD:4890453 |
RGD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
|
IPM |
|
|
|
RGD:2293135 |
RGD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
|
IEP |
|
|
|
RGD:2293135 |
RGD |
| G |
Bmpr1a |
bone morphogenetic protein receptor, type IA |
|
|
ISS |
16 |
10,061,943 |
10,105,854 |
RGD:5129472 |
RGD |
| G |
Bmpr1b |
bone morphogenetic protein receptor, type IB |
|
|
ISS |
2 |
239,727,569 |
239,767,802 |
RGD:5129472 |
RGD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
|
ISS |
9 |
58,327,587 |
58,436,057 |
RGD:5129472 |
RGD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
|
ISS |
9 |
58,327,587 |
58,436,057 |
RGD:1580076 |
RGD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
|
ISS |
9 |
58,327,587 |
58,436,057 |
RGD:5129474 |
RGD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
Disease_progression |
ISS |
9 |
58,327,587 |
58,436,057 |
RGD:5129239 |
RGD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
|
ISS |
9 |
58,327,587 |
58,436,057 |
RGD:5129237 |
RGD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
|
ISS |
9 |
58,327,587 |
58,436,057 |
RGD:5129238 |
RGD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
|
ISS |
9 |
58,327,587 |
58,436,057 |
RGD:7240710 |
OMIM |
| G |
Casr |
calcium-sensing receptor |
|
|
IEP |
11 |
66,084,169 |
66,153,292 |
RGD:7205669 |
RGD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
|
IEP |
4 |
42,956,102 |
42,989,057 |
RGD:1581153 |
RGD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
|
ISS |
4 |
42,956,102 |
42,989,057 |
RGD:1625360 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
IEP |
10 |
70,256,263 |
70,258,061 |
RGD:2307003 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:4891440 |
RGD |
| G |
Cd209c |
CD209c molecule |
|
|
ISS |
12 |
2,236,285 |
2,244,559 |
RGD:5131187 |
RGD |
| G |
Cd28 |
Cd28 molecule |
|
|
ISS |
9 |
59,342,273 |
59,367,743 |
RGD:5131619 |
RGD |
| G |
Cd86 |
CD86 molecule |
|
|
ISS |
11 |
66,215,233 |
66,238,882 |
RGD:4892293 |
RGD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
|
ISS |
9 |
65,907,211 |
66,017,942 |
RGD:7240710 |
OMIM |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
|
ISS |
13 |
88,702,243 |
88,703,153 |
RGD:6482312 |
RGD |
| G |
Ctgf |
connective tissue growth factor |
|
|
IEP |
1 |
21,327,099 |
21,330,215 |
RGD:2314535 |
RGD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
|
ISS |
19 |
10,666,940 |
10,676,424 |
RGD:4891887 |
RGD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
|
IEP |
19 |
10,666,940 |
10,676,424 |
RGD:4891889 |
RGD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
|
ISS |
19 |
10,666,940 |
10,676,424 |
RGD:4891883 |
RGD |
| G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
|
ISS |
8 |
125,033,630 |
125,047,335 |
RGD:4891896 |
RGD |
| G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
|
IEP |
8 |
125,033,630 |
125,047,335 |
RGD:4891893 |
RGD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
|
ISS |
19 |
52,713,150 |
52,721,609 |
RGD:4762683 |
RGD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
|
IED |
19 |
52,713,150 |
52,721,609 |
RGD:4773907 |
RGD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
|
ISS |
X |
25,514,572 |
25,547,181 |
RGD:4762683 |
RGD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
|
IPM |
X |
94,802,078 |
94,803,097 |
RGD:4848274 |
RGD |
| G |
Ece1 |
endothelin converting enzyme 1 |
|
|
IPM |
5 |
156,635,656 |
156,735,783 |
RGD:7243939 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
IEP |
17 |
28,303,886 |
28,309,775 |
RGD:4144128 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
ISS |
17 |
28,303,886 |
28,309,775 |
RGD:4144877 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
ISS |
17 |
28,303,886 |
28,309,775 |
RGD:4144882 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
ISS |
17 |
28,303,886 |
28,309,775 |
RGD:4144865 |
RGD |
| G |
Edn2 |
endothelin 2 |
|
|
ISS |
5 |
140,742,686 |
140,747,580 |
RGD:1580918 |
RGD |
| G |
Ednra |
endothelin receptor type A |
|
|
IPM |
19 |
32,042,366 |
32,108,153 |
RGD:4892283 |
RGD |
| G |
Ednra |
endothelin receptor type A |
|
|
ISS |
19 |
32,042,366 |
32,108,153 |
RGD:4892320 |
RGD |
| G |
Ednra |
endothelin receptor type A |
|
|
ISS |
19 |
32,042,366 |
32,108,153 |
RGD:4144877 |
RGD |
| G |
Ednra |
endothelin receptor type A |
|
|
IED |
19 |
32,042,366 |
32,108,153 |
RGD:1580949 |
RGD |
| G |
Ednrb |
endothelin receptor type B |
|
|
IED |
15 |
87,893,141 |
87,898,700 |
RGD:1580949 |
RGD |
| G |
Ednrb |
endothelin receptor type B |
|
|
ISS |
15 |
87,893,141 |
87,898,700 |
RGD:4144877 |
RGD |
| G |
Ednrb |
endothelin receptor type B |
|
|
IPM |
15 |
87,893,141 |
87,898,700 |
RGD:4892289 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5131626 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5131639 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
ISS |
18 |
27,343,919 |
27,346,117 |
RGD:5131875 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
IEP |
18 |
27,343,919 |
27,346,117 |
RGD:5131883 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
ISS |
18 |
27,343,919 |
27,346,117 |
RGD:5131890 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
ISS |
18 |
27,343,919 |
27,346,117 |
RGD:5131875 |
RGD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
|
IPM |
15 |
45,497,660 |
45,556,101 |
RGD:5688731 |
RGD |
| G |
Esr1 |
estrogen receptor 1 |
|
|
ISS |
1 |
35,523,680 |
35,759,891 |
RGD:4892253 |
RGD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
|
IED |
6 |
98,691,167 |
98,775,299 |
RGD:5508791 |
RGD |
| G |
F5 |
coagulation factor V (proaccelerin, labile factor) |
|
Contributes_to |
ISS |
13 |
79,934,956 |
79,997,285 |
RGD:4892669 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
IPM |
2 |
123,893,314 |
123,947,136 |
RGD:2315911 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISS |
2 |
123,893,314 |
123,947,136 |
RGD:2315911 |
RGD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
|
IPM |
16 |
70,869,974 |
70,910,045 |
RGD:2315911 |
RGD |
| G |
Gata4 |
GATA binding protein 4 |
|
|
IEP |
15 |
42,472,793 |
42,519,569 |
RGD:7207053 |
RGD |
| G |
Gata6 |
GATA binding protein 6 |
|
|
IEP |
18 |
2,504,264 |
2,534,648 |
RGD:2314194 |
RGD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
|
IEP |
20 |
35,409,815 |
35,422,262 |
RGD:7207411 |
RGD |
| G |
Gpr182 |
G protein-coupled receptor 182 |
|
|
IEP |
7 |
67,740,500 |
67,743,356 |
RGD:1625768 |
RGD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
|
IEP |
6 |
96,419,024 |
96,463,891 |
RGD:1601553 |
RGD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
|
IPM |
2 |
27,127,504 |
27,149,580 |
RGD:5508701 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
IEP |
19 |
13,963,139 |
13,969,960 |
RGD:1582715 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
IED |
19 |
13,963,139 |
13,969,960 |
RGD:4145307 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:4145325 |
RGD |
| G |
Hp |
haptoglobin |
|
|
ISS |
19 |
39,443,016 |
39,447,566 |
RGD:1626353 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:4145436 |
RGD |
| G |
Ifngr1 |
interferon gamma receptor 1 |
|
|
ISS |
1 |
14,846,369 |
14,864,804 |
RGD:4892610 |
RGD |
| G |
Il10 |
interleukin 10 |
|
Disease_progression |
ISS |
13 |
43,953,900 |
43,957,766 |
RGD:4142530 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
IEP |
10 |
39,093,512 |
39,096,069 |
RGD:4145600 |
RGD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
|
ISS |
X |
8,758,662 |
8,820,545 |
RGD:4892610 |
RGD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
|
ISS |
X |
8,758,662 |
8,820,545 |
RGD:4892611 |
RGD |
| G |
Il13ra2 |
interleukin 13 receptor, alpha 2 |
|
|
ISS |
X |
30,505,850 |
30,533,002 |
RGD:4892612 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889590 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4142530 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4892610 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143197 |
RGD |
| G |
Il23r |
interleukin 23 receptor |
|
|
ISS |
4 |
97,087,580 |
97,768,978 |
RGD:5096624 |
RGD |
| G |
Il4 |
interleukin 4 |
|
|
ISS |
10 |
39,074,582 |
39,080,134 |
RGD:5128515 |
RGD |
| G |
Il6 |
interleukin 6 |
|
Disease_progression |
ISS |
4 |
456,799 |
461,376 |
RGD:4142530 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
IED |
4 |
456,799 |
461,376 |
RGD:4143246 |
RGD |
| G |
Kcna5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
|
|
ISS |
4 |
162,896,283 |
162,898,091 |
RGD:1627654 |
RGD |
| G |
Kcna5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
|
|
ISS |
4 |
162,896,283 |
162,898,091 |
RGD:1627651 |
RGD |
| G |
Kcna5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
|
|
IED |
4 |
162,896,283 |
162,898,091 |
RGD:7242752 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISS |
20 |
13,191,986 |
13,192,851 |
RGD:4891006 |
RGD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
|
IED |
8 |
4,333,773 |
4,354,284 |
RGD:7207217 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
IED |
3 |
155,985,473 |
155,993,433 |
RGD:7207217 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
IEP |
3 |
155,985,473 |
155,993,433 |
RGD:1642053 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:1642028 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5129210 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
Severity |
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5130155 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
Treatment |
IED |
7 |
98,953,142 |
98,958,060 |
RGD:7240564 |
RGD |
| G |
Nfatc2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
|
|
IPM |
3 |
159,656,032 |
159,773,643 |
RGD:1627651 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
Onset |
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:1580936 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:5132602 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:4891468 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:1580940 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:4891462 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IPM |
4 |
6,158,847 |
6,179,441 |
RGD:4892043 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IED |
4 |
6,158,847 |
6,179,441 |
RGD:4892038 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:4892010 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IEP |
4 |
6,158,847 |
6,179,441 |
RGD:4892004 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:5132631 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:4892042 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:5132602 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:4892009 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:4892039 |
RGD |
| G |
Nox4 |
NADPH oxidase 4 |
|
|
ISS |
1 |
143,415,816 |
143,603,554 |
RGD:4762683 |
RGD |
| G |
Nppb |
natriuretic peptide B |
|
Severity |
ISS |
5 |
165,062,348 |
165,063,650 |
RGD:1642205 |
RGD |
| G |
Nppb |
natriuretic peptide B |
|
|
IEP |
5 |
165,062,348 |
165,063,650 |
RGD:1642203 |
RGD |
| G |
Pde3a |
phosphodiesterase 3A, cGMP inhibited |
|
|
IEP |
4 |
178,658,896 |
178,930,417 |
RGD:1582528 |
RGD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
|
IPM |
2 |
219,410,394 |
219,550,910 |
RGD:2314460 |
RGD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
|
IEP |
12 |
16,151,045 |
16,172,412 |
RGD:1580847 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
IEP |
7 |
118,244,385 |
118,262,021 |
RGD:1580847 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISS |
7 |
118,244,385 |
118,262,021 |
RGD:6482831 |
RGD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
IEP |
18 |
57,014,475 |
57,053,581 |
RGD:1580851 |
RGD |
| G |
Pgf |
placental growth factor |
|
|
ISS |
6 |
109,215,540 |
109,226,122 |
RGD:6483588 |
RGD |
| G |
Pgf |
placental growth factor |
|
|
ISS |
6 |
109,215,540 |
109,226,122 |
RGD:6483610 |
RGD |
| G |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
|
|
IED |
3 |
158,356,878 |
158,387,984 |
RGD:1580695 |
RGD |
| G |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
|
|
ISS |
3 |
158,356,878 |
158,387,984 |
RGD:727270 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
ISS |
13 |
64,427,288 |
64,432,978 |
RGD:5135495 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IPM |
13 |
64,427,288 |
64,432,978 |
RGD:2300276 |
RGD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
|
ISS |
7 |
110,933,298 |
111,084,554 |
RGD:1581290 |
RGD |
| G |
Ramp2 |
receptor (G protein-coupled) activity modifying protein 2 |
|
|
IEP |
10 |
90,275,463 |
90,277,242 |
RGD:1642678 |
RGD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
|
IEP |
1 |
208,262,669 |
208,273,148 |
RGD:2298843 |
RGD |
| G |
Rhoa |
ras homolog family member A |
|
|
IEP |
|
|
|
RGD:2298877 |
RGD |
| G |
Rhoa |
ras homolog family member A |
|
|
IEP |
|
|
|
RGD:1642819 |
RGD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
|
IED |
6 |
127,998,617 |
128,021,719 |
RGD:1643154 |
RGD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
|
ISS |
6 |
127,998,617 |
128,021,719 |
RGD:1643144 |
RGD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
|
ISS |
12 |
20,931,996 |
20,942,374 |
RGD:4143529 |
RGD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
|
ISS |
12 |
20,931,996 |
20,942,374 |
RGD:4143527 |
RGD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
|
IEP |
10 |
56,786,705 |
56,792,209 |
RGD:2313622 |
RGD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
|
ISS |
10 |
67,134,790 |
67,155,891 |
RGD:4889432 |
RGD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
|
IED |
10 |
67,134,790 |
67,155,891 |
RGD:4889445 |
RGD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
|
ISS |
10 |
67,134,790 |
67,155,891 |
RGD:4889430 |
RGD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
|
IPM |
10 |
67,134,790 |
67,155,891 |
RGD:4889437 |
RGD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
Severity |
ISS |
10 |
67,134,790 |
67,155,891 |
RGD:4889434 |
RGD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
No_Association |
ISS |
10 |
67,134,790 |
67,155,891 |
RGD:4889440 |
RGD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
|
ISS |
10 |
67,134,790 |
67,155,891 |
RGD:4889432 |
RGD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
Onset |
ISS |
10 |
67,134,790 |
67,155,891 |
RGD:4889442 |
RGD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
|
IED |
10 |
67,134,790 |
67,155,891 |
RGD:4889435 |
RGD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
|
ISS |
6 |
4,421,046 |
4,691,716 |
RGD:1642711 |
RGD |
| G |
Smad1 |
SMAD family member 1 |
|
|
ISS |
19 |
30,348,886 |
30,409,345 |
RGD:1643222 |
RGD |
| G |
Smad1 |
SMAD family member 1 |
|
|
IEP |
19 |
30,348,886 |
30,409,345 |
RGD:1643222 |
RGD |
| G |
Smad6 |
SMAD family member 6 |
|
|
IEP |
8 |
68,144,395 |
68,214,652 |
RGD:1643222 |
RGD |
| G |
Smad9 |
SMAD family member 9 |
|
|
IEP |
2 |
144,014,436 |
144,030,672 |
RGD:1643222 |
RGD |
| G |
Smad9 |
SMAD family member 9 |
|
|
ISS |
2 |
144,014,436 |
144,030,672 |
RGD:7240710 |
OMIM |
| G |
Tac1 |
tachykinin, precursor 1 |
|
|
IPM |
4 |
32,649,666 |
32,657,632 |
RGD:5147638 |
RGD |
| G |
Tacr1 |
tachykinin receptor 1 |
|
|
IPM |
4 |
116,610,595 |
116,780,394 |
RGD:5147638 |
RGD |
| G |
Tacr2 |
tachykinin receptor 2 |
|
|
IPM |
|
|
|
RGD:5147638 |
RGD |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
|
ISS |
5 |
115,047,195 |
115,196,172 |
RGD:1601487 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
Onset |
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:4145273 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:4145138 |
RGD |
| G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
|
|
IPM |
5 |
63,976,868 |
64,034,058 |
RGD:2302019 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
IEP |
8 |
120,593,595 |
120,680,453 |
RGD:1601116 |
RGD |
| G |
Thbd |
thrombomodulin |
|
|
ISS |
3 |
137,158,955 |
137,162,607 |
RGD:1601639 |
RGD |
| G |
Thpo |
thrombopoietin |
|
|
ISS |
11 |
82,412,552 |
82,417,807 |
RGD:1580087 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144108 |
RGD |
| G |
Tnc |
tenascin C |
|
|
ISS |
|
|
|
RGD:4889562 |
RGD |
| G |
Tnc |
tenascin C |
|
|
ISS |
|
|
|
RGD:4889567 |
RGD |
| G |
Tnc |
tenascin C |
|
|
IED |
|
|
|
RGD:4889570 |
RGD |
| G |
Tnc |
tenascin C |
|
Severity |
IEP |
|
|
|
RGD:4889564 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4142833 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4143280 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4143422 |
RGD |
| G |
Tph1 |
tryptophan hydroxylase 1 |
|
Severity |
ISS |
1 |
97,186,071 |
97,207,551 |
RGD:5686352 |
RGD |
| G |
Tph2 |
tryptophan hydroxylase 2 |
|
Severity |
ISS |
7 |
54,321,033 |
54,430,706 |
RGD:5686352 |
RGD |
| G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
|
ISS |
2 |
123,117,180 |
123,184,016 |
RGD:1580490 |
RGD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
|
ISS |
8 |
5,472,515 |
5,577,537 |
RGD:1580490 |
RGD |
| G |
Uts2 |
urotensin 2 |
|
|
IEP |
5 |
168,143,315 |
168,148,700 |
RGD:2306848 |
RGD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
|
IEP |
2 |
212,277,654 |
212,297,376 |
RGD:2298843 |
RGD |
| G |
Vegfb |
vascular endothelial growth factor B |
|
|
ISS |
1 |
209,657,632 |
209,661,271 |
RGD:1625708 |
RGD |
| G |
Vwf |
von Willebrand factor |
|
|
ISS |
4 |
161,723,415 |
161,854,766 |
RGD:1580645 |
RGD |
| Q |
Cm15 |
Cardiac mass QTL 15 |
|
|
IED |
17 |
65,900,398 |
81,612,488 |
RGD:69699 |
RGD |
Kniest dysplasia
|
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
|
ISS |
7 |
136,679,219 |
136,707,976 |
RGD:7240710 |
OMIM |
Lung Diseases, Fungal
|
| G |
C5 |
complement component 5 |
|
|
ISS |
3 |
14,011,115 |
14,102,744 |
RGD:5130160 |
RGD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
|
ISS |
10 |
70,267,281 |
70,269,131 |
RGD:5129686 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:4145474 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
IEP |
10 |
39,093,512 |
39,096,069 |
RGD:4145506 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:4891455 |
RGD |
| G |
S100b |
S100 calcium binding protein B |
|
|
ISS |
20 |
12,791,440 |
12,824,508 |
RGD:5508765 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
Susceptibility |
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143489 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
Susceptibility |
ISS |
|
|
|
RGD:4143489 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143489 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
IEP |
20 |
3,661,000 |
3,663,618 |
RGD:4145506 |
RGD |
Lung Neoplasms
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
Susceptibility |
ISS |
10 |
95,361,338 |
95,381,455 |
RGD:4140486 |
RGD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
|
IEA |
20 |
4,250,613 |
4,253,540 |
RGD:1331525 |
RGD |
| G |
Alox12 |
arachidonate 12-lipoxygenase |
|
|
ISS |
10 |
57,080,603 |
57,092,874 |
RGD:2313872 |
RGD |
| G |
Atf2 |
activating transcription factor 2 |
|
|
ISS |
3 |
56,403,676 |
56,496,473 |
RGD:704409 |
RGD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
|
ISS |
4 |
67,117,759 |
67,243,058 |
RGD:7240710 |
OMIM |
| G |
Bsg |
basigin (Ok blood group) |
|
|
ISS |
7 |
11,507,914 |
11,515,132 |
RGD:2289059 |
RGD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
|
IEP |
8 |
50,765,645 |
51,108,962 |
RGD:2289096 |
RGD |
| G |
Casp8 |
caspase 8 |
|
|
ISS |
9 |
57,389,353 |
57,437,803 |
RGD:7240710 |
OMIM |
| G |
Ccl22 |
chemokine (C-C motif) ligand 22 |
|
Disease_progression |
ISS |
19 |
10,697,324 |
10,704,129 |
RGD:4891472 |
RGD |
| G |
Cd44 |
Cd44 molecule |
|
|
ISS |
3 |
88,022,962 |
88,110,352 |
RGD:2289345 |
RGD |
| G |
Cdh1 |
cadherin 1 |
|
|
IED |
19 |
36,442,693 |
36,512,091 |
RGD:1599556 |
RGD |
| G |
Cdh13 |
cadherin 13 |
|
|
IED |
19 |
48,507,173 |
49,575,123 |
RGD:2293546 |
RGD |
| G |
Cdh13 |
cadherin 13 |
|
|
ISS |
19 |
48,507,173 |
49,575,123 |
RGD:734736 |
RGD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
|
IAGP |
5 |
108,908,749 |
108,916,380 |
RGD:1298567 |
RGD |
| G |
Chrna3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
|
|
ISS |
8 |
58,570,223 |
58,583,594 |
RGD:7240710 |
OMIM |
| G |
Chrna5 |
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
|
|
ISS |
8 |
58,538,002 |
58,566,388 |
RGD:7240710 |
OMIM |
| G |
Ctnna1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
|
IEP |
18 |
27,629,915 |
27,769,360 |
RGD:2289804 |
RGD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
Disease_progression |
IAGP |
8 |
125,978,161 |
125,987,670 |
RGD:2289843 |
RGD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
|
ISS |
8 |
61,462,207 |
61,468,237 |
RGD:4892075 |
RGD |
| G |
Dlc1 |
deleted in liver cancer 1 |
|
|
ISS |
16 |
59,312,930 |
59,355,129 |
RGD:7240710 |
OMIM |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:5131628 |
RGD |
| G |
Egfr |
epidermal growth factor receptor |
|
|
ISS |
14 |
97,617,358 |
97,788,211 |
RGD:7240710 |
OMIM |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
|
ISS |
10 |
87,219,157 |
87,242,919 |
RGD:7240710 |
OMIM |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
|
IEA |
|
|
|
RGD:1331525 |
RGD |
| G |
Ercc6 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 |
|
|
ISS |
16 |
8,024,881 |
8,091,587 |
RGD:7240710 |
OMIM |
| G |
Fen1 |
flap structure-specific endonuclease 1 |
|
|
ISS |
1 |
212,688,118 |
212,692,486 |
RGD:6484213 |
RGD |
| G |
Ggt5 |
gamma-glutamyltransferase 5 |
|
|
IEP |
|
|
|
RGD:69846 |
RGD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
Resistance |
ISS |
2 |
203,575,444 |
203,580,821 |
RGD:4140941 |
RGD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
|
IEA |
2 |
203,575,444 |
203,580,821 |
RGD:1331525 |
RGD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
Susceptibility |
ISS |
20 |
13,604,355 |
13,621,456 |
RGD:4140924 |
RGD |
| G |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
|
|
ISS |
1 |
180,202,791 |
180,324,718 |
RGD:2317633 |
RGD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
|
IAGP |
1 |
42,253,273 |
42,341,646 |
RGD:1298968 |
RGD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
|
ISS |
10 |
39,220,600 |
39,227,602 |
RGD:7240710 |
OMIM |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:1600465 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:7240710 |
OMIM |
| G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
|
ISS |
17 |
61,910,179 |
61,930,459 |
RGD:7240710 |
OMIM |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
Susceptibility |
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889433 |
RGD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
No_Association |
ISS |
8 |
4,333,773 |
4,354,284 |
RGD:7207056 |
RGD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
|
ISS |
8 |
4,333,773 |
4,354,284 |
RGD:5131088 |
RGD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
|
ISS |
8 |
4,333,773 |
4,354,284 |
RGD:4890379 |
RGD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
Susceptibility |
ISS |
8 |
4,333,773 |
4,354,284 |
RGD:7207021 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
Severity |
ISS |
19 |
15,246,036 |
15,275,061 |
RGD:5130739 |
RGD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
|
ISS |
8 |
4,315,601 |
4,329,146 |
RGD:5129491 |
RGD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
|
ISS |
8 |
4,526,018 |
4,533,730 |
RGD:5129528 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5129491 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5130173 |
RGD |
| G |
Mpo |
myeloperoxidase |
|
|
ISS |
10 |
76,085,872 |
76,097,012 |
RGD:5131088 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:5131260 |
RGD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
Disease_progression |
ISS |
11 |
69,830,276 |
69,858,366 |
RGD:5131208 |
RGD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
|
ISS |
11 |
69,830,276 |
69,858,366 |
RGD:5131258 |
RGD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
Susceptibility |
ISS |
16 |
23,845,894 |
23,876,528 |
RGD:5131605 |
RGD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
No_Association |
ISS |
16 |
23,845,894 |
23,876,528 |
RGD:5131861 |
RGD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
Susceptibility |
IAGP |
16 |
23,855,555 |
23,876,531 |
RGD:5131866 |
RGD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
Susceptibility |
ISS |
19 |
19,662,337 |
19,697,341 |
RGD:5131514 |
RGD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
Susceptibility |
ISS |
19 |
37,251,147 |
37,266,040 |
RGD:5134987 |
RGD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
Susceptibility |
ISS |
19 |
37,251,147 |
37,266,040 |
RGD:5134963 |
RGD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
|
ISS |
1 |
43,151,265 |
44,374,470 |
RGD:7240710 |
OMIM |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISS |
18 |
57,014,475 |
57,053,581 |
RGD:2292176 |
RGD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
|
ISS |
2 |
118,640,277 |
118,672,440 |
RGD:2290476 |
RGD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
|
ISS |
2 |
118,640,277 |
118,672,440 |
RGD:7240710 |
OMIM |
| G |
Plau |
plasminogen activator, urokinase |
|
Severity |
ISS |
15 |
3,680,072 |
3,686,232 |
RGD:7241261 |
RGD |
| G |
Ppp2r1b |
protein phosphatase 2, regulatory subunit A, beta |
|
|
ISS |
8 |
54,208,126 |
54,229,044 |
RGD:7240710 |
OMIM |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IPM |
13 |
64,427,288 |
64,432,978 |
RGD:5135048 |
RGD |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
|
ISS |
8 |
112,798,863 |
112,810,004 |
RGD:2291977 |
RGD |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
|
ISS |
8 |
112,798,863 |
112,810,004 |
RGD:2291979 |
RGD |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
|
ISS |
8 |
112,798,863 |
112,810,004 |
RGD:7240710 |
OMIM |
| G |
Recql |
RecQ protein-like (DNA helicase Q1-like) |
|
|
ISS |
4 |
179,927,255 |
179,951,742 |
RGD:2317370 |
RGD |
| G |
Scgb3a2 |
secretoglobin, family 3A, member 2 |
|
|
ISS |
18 |
37,200,474 |
37,203,396 |
RGD:5147392 |
RGD |
| G |
Scgb3a2 |
secretoglobin, family 3A, member 2 |
|
|
ISS |
18 |
37,200,474 |
37,203,396 |
RGD:5147390 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
Susceptibility |
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143389 |
RGD |
| G |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
|
|
ISS |
8 |
20,720,915 |
20,812,157 |
RGD:2302526 |
RGD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
|
ISS |
1 |
41,862,997 |
41,870,327 |
RGD:1581247 |
RGD |
| G |
Strap |
serine/threonine kinase receptor associated protein |
|
|
ISS |
4 |
174,863,502 |
174,877,750 |
RGD:1581429 |
RGD |
| G |
Tlr9 |
toll-like receptor 9 |
|
|
ISS |
|
|
|
RGD:5130705 |
RGD |
| G |
Tnc |
tenascin C |
|
|
ISS |
|
|
|
RGD:4889612 |
RGD |
| G |
Tp53 |
tumor protein p53 |
|
|
IEA |
10 |
56,399,721 |
56,411,150 |
RGD:1331525 |
RGD |
| G |
Tp73 |
tumor protein p73 |
|
|
ISS |
5 |
170,848,979 |
171,078,739 |
RGD:2291830 |
RGD |
Persistent Fetal Circulation Syndrome
|
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
|
ISS |
9 |
65,907,211 |
66,017,942 |
RGD:1600716 |
RGD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
|
ISS |
9 |
65,907,211 |
66,017,942 |
RGD:7240710 |
OMIM |
Pleuropneumonia
|
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
|
ISS |
4 |
152,610,283 |
152,657,891 |
RGD:4890419 |
RGD |
Pleuropulmonary blastoma
|
| G |
Dicer1 |
dicer 1, ribonuclease type III |
|
|
ISS |
6 |
128,777,468 |
128,838,780 |
RGD:7240710 |
OMIM |
Pneumonia
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
ISS |
10 |
95,361,338 |
95,381,455 |
RGD:4140922 |
RGD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
ISS |
10 |
95,361,338 |
95,381,455 |
RGD:4140916 |
RGD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
Disease_progression |
ISS |
10 |
95,361,338 |
95,381,455 |
RGD:4140918 |
RGD |
| G |
Adora1 |
adenosine A1 receptor |
|
|
ISS |
13 |
47,160,292 |
47,192,804 |
RGD:5129098 |
RGD |
| G |
Adora2a |
adenosine A2a receptor |
|
|
ISS |
20 |
13,815,719 |
13,834,131 |
RGD:4890358 |
RGD |
| G |
Adora2a |
adenosine A2a receptor |
|
|
ISS |
20 |
13,815,719 |
13,834,131 |
RGD:4890376 |
RGD |
| G |
Adora2a |
adenosine A2a receptor |
|
|
ISS |
20 |
13,815,719 |
13,834,131 |
RGD:4890364 |
RGD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
|
IED |
18 |
58,174,958 |
58,177,000 |
RGD:4145041 |
RGD |
| G |
Bdkrb2 |
bradykinin receptor B2 |
|
|
ISS |
6 |
129,744,781 |
129,748,851 |
RGD:4891030 |
RGD |
| G |
C3 |
complement component 3 |
|
|
IED |
|
|
|
RGD:5129562 |
RGD |
| G |
C3ar1 |
complement component 3a receptor 1 |
|
|
ISS |
4 |
159,326,402 |
159,333,433 |
RGD:5129688 |
RGD |
| G |
C5 |
complement component 5 |
|
|
ISS |
3 |
14,011,115 |
14,102,744 |
RGD:5129688 |
RGD |
| G |
C5 |
complement component 5 |
|
|
ISS |
3 |
14,011,115 |
14,102,744 |
RGD:5130161 |
RGD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
|
IPM |
10 |
70,279,161 |
70,283,762 |
RGD:4145450 |
RGD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
|
IEP |
10 |
70,279,161 |
70,283,762 |
RGD:4145445 |
RGD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
|
IEP |
19 |
10,641,376 |
10,642,827 |
RGD:2306304 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:4891461 |
RGD |
| G |
Ccl22 |
chemokine (C-C motif) ligand 22 |
|
|
IEP |
19 |
10,697,324 |
10,704,129 |
RGD:2306304 |
RGD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
|
ISS |
10 |
70,267,281 |
70,269,131 |
RGD:5130985 |
RGD |
| G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
|
ISS |
8 |
128,693,658 |
128,699,213 |
RGD:5688175 |
RGD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
|
ISS |
8 |
128,892,784 |
128,893,905 |
RGD:4145068 |
RGD |
| G |
Ccr3 |
chemokine (C-C motif) receptor 3 |
|
|
ISS |
8 |
128,759,943 |
128,769,341 |
RGD:4145622 |
RGD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
|
ISS |
8 |
128,907,157 |
128,912,272 |
RGD:4892103 |
RGD |
| G |
Ccr7 |
chemokine (C-C motif) receptor 7 |
|
|
ISS |
10 |
87,925,093 |
87,936,325 |
RGD:5130919 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
|
ISS |
18 |
29,374,593 |
29,376,190 |
RGD:4144794 |
RGD |
| G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
|
ISS |
4 |
83,839,822 |
83,867,017 |
RGD:5130933 |
RGD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
Severity |
ISS |
13 |
88,702,243 |
88,703,153 |
RGD:5131283 |
RGD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
Disease_progression |
ISS |
13 |
88,702,243 |
88,703,153 |
RGD:5131291 |
RGD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
|
ISS |
10 |
39,665,850 |
39,667,831 |
RGD:4142837 |
RGD |
| G |
Csk |
c-src tyrosine kinase |
|
|
ISS |
8 |
61,381,336 |
61,386,013 |
RGD:5134363 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
IEP |
14 |
18,690,339 |
18,692,118 |
RGD:5134959 |
RGD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
|
ISS |
14 |
17,265,986 |
17,268,183 |
RGD:5135491 |
RGD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
|
ISS |
14 |
17,265,986 |
17,268,183 |
RGD:5135445 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
ISS |
14 |
18,677,129 |
18,679,175 |
RGD:5135235 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
IEP |
14 |
18,677,129 |
18,679,175 |
RGD:5134959 |
RGD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
|
ISS |
14 |
18,825,357 |
18,826,269 |
RGD:5135259 |
RGD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
|
ISS |
14 |
17,284,085 |
17,288,996 |
RGD:5135440 |
RGD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
|
ISS |
14 |
17,284,085 |
17,288,996 |
RGD:5135445 |
RGD |
| G |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
|
|
ISS |
X |
89,794,276 |
89,796,927 |
RGD:5135445 |
RGD |
| G |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
|
|
ISS |
X |
89,794,276 |
89,796,927 |
RGD:5135491 |
RGD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
Susceptibility |
ISS |
8 |
61,462,207 |
61,468,237 |
RGD:4142512 |
RGD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
|
ISS |
1 |
200,918,521 |
200,928,919 |
RGD:4892223 |
RGD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
|
ISS |
1 |
200,918,521 |
200,928,919 |
RGD:4142512 |
RGD |
| G |
Defb1 |
defensin beta 1 |
|
|
ISS |
16 |
74,980,054 |
74,995,445 |
RGD:4892262 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
Severity |
ISS |
17 |
28,303,886 |
28,309,775 |
RGD:4144879 |
RGD |
| G |
Egf |
epidermal growth factor |
|
Resistance |
ISS |
2 |
227,103,900 |
227,195,062 |
RGD:6906904 |
RGD |
| G |
Hdc |
histidine decarboxylase |
|
|
ISS |
3 |
114,119,316 |
114,138,107 |
RGD:5143922 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
Susceptibility |
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:1601608 |
RGD |
| G |
Ifnar1 |
interferon (alpha, beta and omega) receptor 1 |
|
|
ISS |
11 |
31,454,789 |
31,478,449 |
RGD:5490275 |
RGD |
| G |
Il10 |
interleukin 10 |
|
Disease_progression |
ISS |
13 |
43,953,900 |
43,957,766 |
RGD:4140400 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:4145774 |
RGD |
| G |
Il13ra2 |
interleukin 13 receptor, alpha 2 |
|
|
ISS |
X |
30,505,850 |
30,533,002 |
RGD:4890021 |
RGD |
| G |
Il17a |
interleukin 17A |
|
|
ISS |
9 |
19,454,979 |
19,458,467 |
RGD:4888524 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889825 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889590 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889836 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
IEP |
8 |
53,936,584 |
53,943,228 |
RGD:729357 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4142812 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4142831 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IEP |
3 |
116,964,422 |
116,970,867 |
RGD:4142536 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4142827 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4143211 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
No_Association |
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143204 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143213 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
Disease_progression |
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4142865 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4142871 |
RGD |
| G |
Il27 |
interleukin 27 |
|
|
ISS |
1 |
185,730,394 |
185,735,604 |
RGD:5128483 |
RGD |
| G |
Il6 |
interleukin 6 |
|
Disease_progression |
ISS |
4 |
456,799 |
461,376 |
RGD:4140400 |
RGD |
| G |
Itgb2 |
integrin, beta 2 |
|
|
IPM |
20 |
11,446,521 |
11,485,009 |
RGD:6482228 |
RGD |
| G |
Itgb3 |
integrin, beta 3 |
|
Disease_progression |
ISS |
|
|
|
RGD:5100478 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
|
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889459 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
Severity |
ISS |
20 |
13,191,986 |
13,192,851 |
RGD:4891058 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5130157 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:5131281 |
RGD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
|
ISS |
12 |
20,931,996 |
20,942,374 |
RGD:4143511 |
RGD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
Disease_progression |
ISS |
12 |
20,931,996 |
20,942,374 |
RGD:4143525 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143394 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143452 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143394 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143393 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143412 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:4143394 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143504 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143517 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143394 |
RGD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
|
IPM |
7 |
139,094,505 |
139,127,427 |
RGD:5688709 |
RGD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
|
ISS |
14 |
63,381,447 |
63,387,180 |
RGD:1581268 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
Severity |
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:4145141 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:4145120 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
Susceptibility |
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:4145330 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4142858 |
RGD |
| G |
Tnc |
tenascin C |
|
|
ISS |
|
|
|
RGD:4889573 |
RGD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
Susceptibility |
ISS |
5 |
163,666,541 |
163,697,484 |
RGD:5131286 |
RGD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
|
ISS |
5 |
163,666,541 |
163,697,484 |
RGD:5131448 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
|
ISS |
7 |
136,567,614 |
136,617,280 |
RGD:4889851 |
RGD |
Pneumonia, Aspiration
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
ISS |
10 |
95,361,338 |
95,381,455 |
RGD:4140926 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
IEP |
14 |
18,690,339 |
18,692,118 |
RGD:4891456 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
IEP |
14 |
18,677,129 |
18,679,175 |
RGD:4891456 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
IEP |
17 |
28,303,886 |
28,309,775 |
RGD:4145069 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
|
IEP |
3 |
116,913,612 |
116,924,114 |
RGD:4142854 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
IEP |
20 |
3,661,000 |
3,663,618 |
RGD:4142854 |
RGD |
Pneumonia, Bacterial
|
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
|
ISS |
10 |
452,239 |
575,705 |
RGD:5128828 |
RGD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
Severity |
ISS |
20 |
4,250,613 |
4,253,540 |
RGD:6767559 |
RGD |
| G |
C3 |
complement component 3 |
|
|
ISS |
|
|
|
RGD:5129508 |
RGD |
| G |
C3ar1 |
complement component 3a receptor 1 |
|
|
ISS |
4 |
159,326,402 |
159,333,433 |
RGD:5129690 |
RGD |
| G |
C5 |
complement component 5 |
|
|
ISS |
3 |
14,011,115 |
14,102,744 |
RGD:5129707 |
RGD |
| G |
Cat |
catalase |
|
|
IED |
3 |
88,654,077 |
88,686,212 |
RGD:5130748 |
RGD |
| G |
Ccl19 |
chemokine (C-C motif) ligand 19 |
|
|
ISS |
5 |
59,221,738 |
59,223,682 |
RGD:5130918 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:4891443 |
RGD |
| G |
Ccl21 |
chemokine (C-C motif) ligand 21 |
|
|
ISS |
5 |
59,238,897 |
59,240,001 |
RGD:5130918 |
RGD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
|
ISS |
10 |
71,759,643 |
71,761,115 |
RGD:5130905 |
RGD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
|
ISS |
8 |
128,892,784 |
128,893,905 |
RGD:4891443 |
RGD |
| G |
Ccr7 |
chemokine (C-C motif) receptor 7 |
|
|
ISS |
10 |
87,925,093 |
87,936,325 |
RGD:5130918 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
|
ISS |
18 |
29,374,593 |
29,376,190 |
RGD:4144197 |
RGD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
ISS |
3 |
156,092,602 |
156,107,427 |
RGD:5132268 |
RGD |
| G |
Cd80 |
Cd80 molecule |
|
|
ISS |
11 |
64,045,358 |
64,070,072 |
RGD:4892562 |
RGD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
|
ISS |
1 |
249,122,845 |
249,158,369 |
RGD:5133701 |
RGD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
Disease_progression |
ISS |
10 |
87,473,990 |
87,476,365 |
RGD:5133733 |
RGD |
| G |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
|
Disease_progression |
ISS |
5 |
145,374,596 |
145,394,045 |
RGD:5133739 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
IEP |
14 |
18,690,339 |
18,692,118 |
RGD:5135234 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
ISS |
14 |
18,690,339 |
18,692,118 |
RGD:5135062 |
RGD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
Severity |
ISS |
14 |
17,265,986 |
17,268,183 |
RGD:5135458 |
RGD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
|
ISS |
14 |
17,265,986 |
17,268,183 |
RGD:5135459 |
RGD |
| G |
Cxcl11 |
chemokine (C-X-C motif) ligand 11 |
|
|
ISS |
14 |
17,250,648 |
17,253,423 |
RGD:5135459 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
IEP |
14 |
18,677,129 |
18,679,175 |
RGD:5135234 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
Severity |
ISS |
14 |
18,677,129 |
18,679,175 |
RGD:5135065 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
ISS |
14 |
18,677,129 |
18,679,175 |
RGD:5135062 |
RGD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
|
IEP |
14 |
18,767,306 |
18,787,340 |
RGD:5135234 |
RGD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
|
ISS |
14 |
18,825,357 |
18,826,269 |
RGD:4145490 |
RGD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
|
ISS |
14 |
17,284,085 |
17,288,996 |
RGD:5135459 |
RGD |
| G |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
|
|
ISS |
X |
89,794,276 |
89,796,927 |
RGD:5135459 |
RGD |
| G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
|
|
IEP |
5 |
116,702,370 |
116,729,722 |
RGD:1625385 |
RGD |
| G |
Defb4 |
defensin beta 4 |
|
|
ISS |
16 |
75,442,005 |
75,445,196 |
RGD:4892266 |
RGD |
| G |
F2 |
coagulation factor II |
|
|
IEP |
3 |
76,005,318 |
76,018,603 |
RGD:6893486 |
RGD |
| G |
Fcgr2a |
Fc fragment of IgG, low affinity IIa, receptor |
|
|
ISS |
13 |
86,898,651 |
86,911,743 |
RGD:5129707 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:4145490 |
RGD |
| G |
Ifnar1 |
interferon (alpha, beta and omega) receptor 1 |
|
|
ISS |
11 |
31,454,789 |
31,478,449 |
RGD:5490274 |
RGD |
| G |
Il15 |
interleukin 15 |
|
|
ISS |
19 |
27,487,268 |
27,498,973 |
RGD:5000754 |
RGD |
| G |
Il17a |
interleukin 17A |
|
|
ISS |
9 |
19,454,979 |
19,458,467 |
RGD:4889153 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889913 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4143205 |
RGD |
| G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
|
ISS |
9 |
39,577,879 |
39,624,781 |
RGD:5144223 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143205 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143206 |
RGD |
| G |
Il22 |
interleukin 22 |
|
|
ISS |
7 |
57,517,321 |
57,521,786 |
RGD:5147404 |
RGD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
|
ISS |
10 |
39,220,600 |
39,227,602 |
RGD:5128725 |
RGD |
| G |
Irf3 |
interferon regulatory factor 3 |
|
|
ISS |
1 |
95,470,284 |
95,475,078 |
RGD:4891951 |
RGD |
| G |
Itgb3 |
integrin, beta 3 |
|
|
IEP |
|
|
|
RGD:4993468 |
RGD |
| G |
Lep |
leptin |
|
|
ISS |
4 |
55,943,837 |
55,945,938 |
RGD:5128871 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
|
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889477 |
RGD |
| G |
Mc1r |
melanocortin 1 receptor |
|
|
ISS |
|
|
|
RGD:5687324 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5130727 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5129533 |
RGD |
| G |
Mpo |
myeloperoxidase |
|
|
ISS |
10 |
76,085,872 |
76,097,012 |
RGD:5130992 |
RGD |
| G |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
|
|
ISS |
4 |
83,398,809 |
83,449,207 |
RGD:5131449 |
RGD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
ISS |
19 |
19,662,337 |
19,697,341 |
RGD:5131449 |
RGD |
| G |
Pdpn |
podoplanin |
|
|
IEP |
5 |
162,142,251 |
162,175,921 |
RGD:2292375 |
RGD |
| G |
Pgf |
placental growth factor |
|
|
ISS |
6 |
109,215,540 |
109,226,122 |
RGD:6483601 |
RGD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
Severity |
ISS |
12 |
20,931,996 |
20,942,374 |
RGD:4144840 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
IEP |
16 |
17,570,887 |
17,574,389 |
RGD:4143464 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
IEP |
4 |
105,609,410 |
105,618,452 |
RGD:4143464 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143403 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:4144114 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
IEP |
15 |
50,923,105 |
50,926,047 |
RGD:4143464 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
IEP |
|
|
|
RGD:4143464 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143403 |
RGD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
|
ISS |
10 |
89,821,078 |
89,872,970 |
RGD:6892945 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
IED |
2 |
175,607,990 |
175,613,992 |
RGD:4889533 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:4145337 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144172 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144197 |
RGD |
| G |
Tlr5 |
toll-like receptor 5 |
|
|
ISS |
13 |
99,025,501 |
99,029,755 |
RGD:5129503 |
RGD |
| G |
Tlr6 |
toll-like receptor 6 |
|
|
IED |
14 |
46,089,365 |
46,100,687 |
RGD:4889533 |
RGD |
| G |
Tlr9 |
toll-like receptor 9 |
|
|
ISS |
|
|
|
RGD:5130719 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
Disease_progression |
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4143476 |
RGD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
|
ISS |
4 |
162,172,563 |
162,185,252 |
RGD:5131429 |
RGD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
|
ISS |
5 |
163,666,541 |
163,697,484 |
RGD:5131429 |
RGD |
Pneumonia, Mycoplasma
|
| G |
Ada |
adenosine deaminase |
|
|
ISS |
3 |
154,636,530 |
154,660,637 |
RGD:5128857 |
RGD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
|
ISS |
10 |
71,759,643 |
71,761,115 |
RGD:4892091 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:4891914 |
RGD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
|
ISS |
8 |
128,907,157 |
128,912,272 |
RGD:4892091 |
RGD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
|
ISS |
13 |
88,702,243 |
88,703,153 |
RGD:5131292 |
RGD |
| G |
Hdc |
histidine decarboxylase |
|
|
ISS |
3 |
114,119,316 |
114,138,107 |
RGD:5143920 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:4145765 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4145765 |
RGD |
Pneumonia, Pneumococcal
|
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
|
ISS |
4 |
152,610,283 |
152,657,891 |
RGD:4890435 |
RGD |
| G |
C3 |
complement component 3 |
|
Disease_progression |
IEP |
|
|
|
RGD:5129523 |
RGD |
| G |
C3 |
complement component 3 |
|
|
ISS |
|
|
|
RGD:5130163 |
RGD |
| G |
C3 |
complement component 3 |
|
|
ISS |
|
|
|
RGD:5129509 |
RGD |
| G |
C5 |
complement component 5 |
|
Severity |
ISS |
3 |
14,011,115 |
14,102,744 |
RGD:5130159 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
Susceptibility |
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:4892130 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
|
ISS |
18 |
29,374,593 |
29,376,190 |
RGD:4144788 |
RGD |
| G |
Chi3l1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
|
|
ISS |
13 |
47,139,658 |
47,147,591 |
RGD:4892626 |
RGD |
| G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
|
ISS |
10 |
93,312,405 |
93,354,229 |
RGD:5147472 |
RGD |
| G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
|
ISS |
4 |
83,839,822 |
83,867,017 |
RGD:5147472 |
RGD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
Disease_progression |
ISS |
13 |
88,702,243 |
88,703,153 |
RGD:5131293 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
ISS |
14 |
18,690,339 |
18,692,118 |
RGD:5134957 |
RGD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
|
ISS |
14 |
17,284,085 |
17,288,996 |
RGD:5135285 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:4145366 |
RGD |
| G |
Hp |
haptoglobin |
|
|
ISS |
19 |
39,443,016 |
39,447,566 |
RGD:5147385 |
RGD |
| G |
Il15 |
interleukin 15 |
|
|
ISS |
19 |
27,487,268 |
27,498,973 |
RGD:5000755 |
RGD |
| G |
Il15ra |
interleukin 15 receptor, alpha |
|
|
ISS |
17 |
77,998,621 |
78,029,657 |
RGD:5000755 |
RGD |
| G |
Il17a |
interleukin 17A |
|
|
ISS |
9 |
19,454,979 |
19,458,467 |
RGD:4888531 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889960 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:4143255 |
RGD |
| G |
Lep |
leptin |
|
|
ISS |
4 |
55,943,837 |
55,945,938 |
RGD:5128869 |
RGD |
| G |
Lepr |
leptin receptor |
|
|
ISS |
5 |
122,320,075 |
122,503,449 |
RGD:5128846 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
No_Association |
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889477 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
|
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889478 |
RGD |
| G |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
|
|
ISS |
4 |
83,398,809 |
83,449,207 |
RGD:5131480 |
RGD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
ISS |
19 |
19,662,337 |
19,697,341 |
RGD:5131480 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:4891950 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
Severity |
ISS |
|
|
|
RGD:4143519 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:4145321 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4143479 |
RGD |
Pneumonia, Pneumocystis
|
| G |
C3 |
complement component 3 |
|
|
IEP |
|
|
|
RGD:5129525 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:4891428 |
RGD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
|
IEP |
10 |
39,665,850 |
39,667,831 |
RGD:5131475 |
RGD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
|
ISS |
2 |
181,399,482 |
181,403,640 |
RGD:5131424 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:4144112 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:4891486 |
RGD |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
|
IEP |
20 |
4,730,559 |
4,736,201 |
RGD:4144112 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143431 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143431 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:4143431 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143431 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:4145341 |
RGD |
Pneumonia, Staphylococcal
|
| G |
Cd86 |
CD86 molecule |
|
|
ISS |
11 |
66,215,233 |
66,238,882 |
RGD:4892562 |
RGD |
| G |
Fn1 |
fibronectin 1 |
|
|
IED |
9 |
70,702,181 |
70,771,155 |
RGD:7205474 |
RGD |
| G |
Ifnar1 |
interferon (alpha, beta and omega) receptor 1 |
|
|
ISS |
11 |
31,454,789 |
31,478,449 |
RGD:5490273 |
RGD |
| G |
Il15 |
interleukin 15 |
|
|
ISS |
19 |
27,487,268 |
27,498,973 |
RGD:4996474 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4142828 |
RGD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
ISS |
19 |
19,662,337 |
19,697,341 |
RGD:5131444 |
RGD |
Pneumonia, Ventilator-Associated
|
| G |
Gc |
group specific component |
|
|
ISS |
14 |
20,166,243 |
20,197,060 |
RGD:5509873 |
RGD |
Pneumonia, Viral
|
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
|
ISS |
10 |
70,279,161 |
70,283,762 |
RGD:4140459 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:4891451 |
RGD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
|
ISS |
10 |
71,759,643 |
71,761,115 |
RGD:5130904 |
RGD |
| G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
|
ISS |
8 |
128,693,658 |
128,699,213 |
RGD:5688163 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
IEP |
14 |
18,690,339 |
18,692,118 |
RGD:5134975 |
RGD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
|
ISS |
14 |
17,265,986 |
17,268,183 |
RGD:5135437 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
|
IEP |
14 |
18,677,129 |
18,679,175 |
RGD:5134975 |
RGD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
|
ISS |
14 |
17,284,085 |
17,288,996 |
RGD:5135437 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:4145417 |
RGD |
| G |
Ifnar1 |
interferon (alpha, beta and omega) receptor 1 |
|
|
ISS |
11 |
31,454,789 |
31,478,449 |
RGD:5490272 |
RGD |
| G |
Il15 |
interleukin 15 |
|
|
ISS |
19 |
27,487,268 |
27,498,973 |
RGD:4892670 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISS |
20 |
13,191,986 |
13,192,851 |
RGD:4891005 |
RGD |
| G |
Tlr9 |
toll-like receptor 9 |
|
|
ISS |
|
|
|
RGD:5130766 |
RGD |
Pulmonary Alveolar Proteinosis
|
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
|
ISS |
10 |
71,759,643 |
71,761,115 |
RGD:4143497 |
RGD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
|
ISS |
10 |
39,665,850 |
39,667,831 |
RGD:5131467 |
RGD |
| G |
Defb1 |
defensin beta 1 |
|
|
ISS |
16 |
74,980,054 |
74,995,445 |
RGD:4892262 |
RGD |
| G |
Defb4 |
defensin beta 4 |
|
|
ISS |
16 |
75,442,005 |
75,445,196 |
RGD:4892262 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143454 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
Severity |
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143411 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143450 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143411 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143392 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143454 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143497 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
ISS |
|
|
|
RGD:4143461 |
RGD |
Pulmonary arterial hypertension
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686821 |
RGD |
| G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
|
|
ISS |
5 |
116,702,370 |
116,729,722 |
RGD:7243137 |
RGD |
| G |
Hp |
haptoglobin |
|
|
ISS |
19 |
39,443,016 |
39,447,566 |
RGD:5147440 |
RGD |
| G |
Hp |
haptoglobin |
|
|
ISS |
19 |
39,443,016 |
39,447,566 |
RGD:5147420 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
IEP |
7 |
118,244,385 |
118,262,021 |
RGD:6482859 |
RGD |
| G |
Vip |
vasoactive intestinal peptide |
|
|
IED |
1 |
36,361,513 |
36,369,594 |
RGD:5685374 |
RGD |
Pulmonary Aspergillosis
|
| G |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
|
|
ISS |
X |
89,794,276 |
89,796,927 |
RGD:5135501 |
RGD |
Pulmonary Blastoma
|
| G |
Dicer1 |
dicer 1, ribonuclease type III |
|
|
ISS |
6 |
128,777,468 |
128,838,780 |
RGD:7240710 |
OMIM |
Pulmonary Embolism
|
| G |
Ctgf |
connective tissue growth factor |
|
|
IEP |
1 |
21,327,099 |
21,330,215 |
RGD:2314488 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
Severity |
IEP |
17 |
28,303,886 |
28,309,775 |
RGD:4144858 |
RGD |
| G |
F13a1 |
coagulation factor XIII, A1 polypeptide |
|
|
ISS |
17 |
34,093,525 |
34,270,498 |
RGD:1581021 |
RGD |
| G |
F5 |
coagulation factor V (proaccelerin, labile factor) |
|
|
ISS |
13 |
79,934,956 |
79,997,285 |
RGD:4892657 |
RGD |
| G |
Fga |
fibrinogen alpha chain |
|
|
IEP |
2 |
174,737,640 |
174,753,598 |
RGD:5688769 |
RGD |
| G |
Fgb |
fibrinogen beta chain |
|
|
IEP |
2 |
174,768,193 |
174,775,102 |
RGD:5688769 |
RGD |
| G |
Fgg |
fibrinogen gamma chain |
|
|
IEP |
2 |
174,727,312 |
174,734,594 |
RGD:5688769 |
RGD |
| G |
Hp |
haptoglobin |
|
|
ISS |
19 |
39,443,016 |
39,447,566 |
RGD:5147425 |
RGD |
| G |
Hp |
haptoglobin |
|
|
IEP |
19 |
39,443,016 |
39,447,566 |
RGD:5147419 |
RGD |
| G |
Hp |
haptoglobin |
|
|
IEP |
19 |
39,443,016 |
39,447,566 |
RGD:1626365 |
RGD |
| G |
Mertk |
c-mer proto-oncogene tyrosine kinase |
|
Model |
ISS |
3 |
116,308,387 |
116,416,414 |
RGD:1582496 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
Model |
IED |
19 |
15,246,036 |
15,275,061 |
RGD:1582630 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
IED |
3 |
155,985,473 |
155,993,433 |
RGD:1582630 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IEP |
4 |
6,158,847 |
6,179,441 |
RGD:2292151 |
RGD |
| G |
Pros1 |
protein S (alpha) |
|
|
ISS |
|
|
|
RGD:1578677 |
RGD |
| G |
Serpinf2 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
|
|
ISS |
10 |
62,748,116 |
62,756,200 |
RGD:1580302 |
RGD |
| G |
Tbxas1 |
thromboxane A synthase 1, platelet |
|
|
IED |
4 |
66,502,253 |
66,677,538 |
RGD:1601456 |
RGD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
|
IEP |
2 |
212,277,654 |
212,297,376 |
RGD:7240517 |
RGD |
Pulmonary Emphysema
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686887 |
RGD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
Disease_progression |
ISS |
10 |
70,279,161 |
70,283,762 |
RGD:4145393 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
Disease_progression |
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:4891458 |
RGD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
|
ISS |
8 |
128,907,157 |
128,912,272 |
RGD:4892098 |
RGD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
|
ISS |
8 |
128,907,157 |
128,912,272 |
RGD:4892104 |
RGD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
|
ISS |
8 |
128,907,157 |
128,912,272 |
RGD:4892090 |
RGD |
| G |
Chi3l1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
|
|
ISS |
13 |
47,139,658 |
47,147,591 |
RGD:4892658 |
RGD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
|
ISS |
19 |
10,666,940 |
10,676,424 |
RGD:4891888 |
RGD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
|
ISS |
14 |
18,690,339 |
18,692,118 |
RGD:5135245 |
RGD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
|
ISS |
14 |
17,265,986 |
17,268,183 |
RGD:4892104 |
RGD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
|
ISS |
14 |
18,767,306 |
18,787,340 |
RGD:5135245 |
RGD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
|
ISS |
14 |
18,825,357 |
18,826,269 |
RGD:5135245 |
RGD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
|
ISS |
14 |
17,284,085 |
17,288,996 |
RGD:4892104 |
RGD |
| G |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
|
|
ISS |
X |
89,794,276 |
89,796,927 |
RGD:4892104 |
RGD |
| G |
Defb1 |
defensin beta 1 |
|
|
ISS |
16 |
74,980,054 |
74,995,445 |
RGD:4892249 |
RGD |
| G |
Ednra |
endothelin receptor type A |
|
|
IPM |
19 |
32,042,366 |
32,108,153 |
RGD:4892307 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
ISS |
18 |
27,343,919 |
27,346,117 |
RGD:5131973 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
|
ISS |
18 |
27,343,919 |
27,346,117 |
RGD:5131892 |
RGD |
| G |
Egr1 |
early growth response 1 |
|
Resistance |
ISS |
18 |
27,343,919 |
27,346,117 |
RGD:5131853 |
RGD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
|
ISS |
13 |
96,722,973 |
96,752,940 |
RGD:4140935 |
RGD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
No_Association |
ISS |
13 |
96,722,973 |
96,752,940 |
RGD:4889406 |
RGD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
Susceptibility |
ISS |
13 |
96,722,973 |
96,752,940 |
RGD:1601065 |
RGD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
|
ISS |
13 |
96,722,973 |
96,752,940 |
RGD:4889405 |
RGD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
|
IED |
8 |
82,724,429 |
82,762,848 |
RGD:5134681 |
RGD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
Susceptibility |
ISS |
2 |
203,575,444 |
203,580,821 |
RGD:4140927 |
RGD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
|
ISS |
2 |
203,532,363 |
203,537,135 |
RGD:5135041 |
RGD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
|
ISS |
1 |
206,627,398 |
206,629,866 |
RGD:4140935 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
Susceptibility |
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:1601606 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:7240710 |
OMIM |
| G |
Il13 |
interleukin 13 |
|
|
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:4145652 |
RGD |
| G |
Il17ra |
interleukin 17 receptor A |
|
|
ISS |
4 |
156,838,353 |
156,862,345 |
RGD:5144212 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889590 |
RGD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
|
ISS |
8 |
20,259,178 |
20,266,351 |
RGD:5134973 |
RGD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
Onset |
ISS |
8 |
20,259,178 |
20,266,351 |
RGD:6893395 |
RGD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
|
ISS |
8 |
4,333,773 |
4,354,284 |
RGD:4890375 |
RGD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
|
IEP |
19 |
15,246,036 |
15,275,061 |
RGD:4892307 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5130151 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
IEP |
3 |
155,985,473 |
155,993,433 |
RGD:4892307 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:4892307 |
RGD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
|
ISS |
3 |
58,366,693 |
58,394,116 |
RGD:5134973 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:5509103 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:4891488 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:4891415 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:4891415 |
RGD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
|
ISS |
19 |
37,251,147 |
37,266,040 |
RGD:5134973 |
RGD |
| G |
Pgf |
placental growth factor |
|
|
ISS |
6 |
109,215,540 |
109,226,122 |
RGD:5135245 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
ISS |
14 |
64,278,115 |
64,370,912 |
RGD:7242020 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IMP |
13 |
64,427,288 |
64,432,978 |
RGD:4891488 |
RGD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
|
ISS |
6 |
127,998,617 |
128,021,719 |
RGD:4892126 |
RGD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
|
ISS |
6 |
127,998,617 |
128,021,719 |
RGD:4892125 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
Susceptibility |
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:4144115 |
RGD |
| G |
Tacr1 |
tachykinin receptor 1 |
|
|
ISS |
4 |
116,610,595 |
116,780,394 |
RGD:5147818 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
Severity |
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:4145272 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:737734 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:4145342 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144170 |
RGD |
Pulmonary Eosinophilia
|
| G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
|
ISS |
1 |
199,780,772 |
199,791,855 |
RGD:5128874 |
RGD |
| G |
Ccl1 |
chemokine (C-C motif) ligand 1 |
|
|
ISS |
10 |
70,380,498 |
70,383,276 |
RGD:4891412 |
RGD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
|
ISS |
10 |
70,279,161 |
70,283,762 |
RGD:4145437 |
RGD |
| G |
Ccl17 |
chemokine (C-C motif) ligand 17 |
|
|
ISS |
19 |
10,641,376 |
10,642,827 |
RGD:4145602 |
RGD |
| G |
Ccr3 |
chemokine (C-C motif) receptor 3 |
|
|
ISS |
8 |
128,759,943 |
128,769,341 |
RGD:4145617 |
RGD |
| G |
Cd44 |
Cd44 molecule |
|
|
ISS |
3 |
88,022,962 |
88,110,352 |
RGD:4145437 |
RGD |
| G |
Il10 |
interleukin 10 |
|
|
ISS |
13 |
43,953,900 |
43,957,766 |
RGD:4140455 |
RGD |
| G |
Il5 |
interleukin 5 |
|
|
ISS |
10 |
39,177,786 |
39,180,657 |
RGD:4890961 |
RGD |
| G |
Il5 |
interleukin 5 |
|
|
ISS |
10 |
39,177,786 |
39,180,657 |
RGD:4890956 |
RGD |
| G |
Il5 |
interleukin 5 |
|
|
ISS |
10 |
39,177,786 |
39,180,657 |
RGD:4890941 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:4891506 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISS |
4 |
6,158,847 |
6,179,441 |
RGD:4892061 |
RGD |
| G |
Scgb1a1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
|
|
ISS |
1 |
211,758,103 |
211,761,651 |
RGD:5144148 |
RGD |
Respiratory Distress Syndrome, Newborn
|
| G |
Abca3 |
ATP-binding cassette, subfamily A (ABC1), member 3 |
|
|
ISS |
10 |
13,619,865 |
13,665,066 |
RGD:1549859 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
ISS |
19 |
13,963,139 |
13,969,960 |
RGD:4145353 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
IEP |
8 |
20,040,177 |
20,051,939 |
RGD:4145493 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISS |
8 |
20,040,177 |
20,051,939 |
RGD:4145440 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISS |
20 |
13,191,986 |
13,192,851 |
RGD:4891007 |
RGD |
| G |
Npsr1 |
neuropeptide S receptor 1 |
|
|
ISS |
8 |
23,736,081 |
23,970,242 |
RGD:4891932 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
Susceptibility |
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4143433 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
|
IEP |
16 |
17,570,887 |
17,574,389 |
RGD:4143428 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
Susceptibility |
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143418 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
Susceptibility |
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143433 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143455 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143416 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:4143376 |
RGD |
| G |
Sftpb |
surfactant protein B |
|
|
IEP |
4 |
105,609,410 |
105,618,452 |
RGD:4143428 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
IEP |
15 |
50,923,105 |
50,926,047 |
RGD:4143428 |
RGD |
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:4144127 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
Susceptibility |
ISS |
|
|
|
RGD:4143507 |
RGD |
| G |
Sftpd |
surfactant protein D |
|
|
IEP |
|
|
|
RGD:4143428 |
RGD |
Schimke immunoosseous dysplasia
|
| G |
Smarcal1 |
Swi/SNF related matrix associated, actin dependent regulator of chromatin, subfamily a-like 1 |
|
|
ISS |
9 |
71,780,870 |
71,827,780 |
RGD:7240710 |
OMIM |
Small Cell Lung Carcinoma
|
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
Severity |
ISS |
5 |
165,112,850 |
165,126,885 |
RGD:4891158 |
RGD |
Spinal muscular atrophy with respiratory distress 1
|
| G |
Ighmbp2 |
immunoglobulin mu binding protein 2 |
|
|
ISS |
1 |
205,792,891 |
205,815,212 |
RGD:7240710 |
OMIM |
Surfactant Metabolism Dysfunction, Pulmonary, 1
|
| G |
Sftpb |
surfactant protein B |
|
|
ISS |
4 |
105,609,410 |
105,618,452 |
RGD:7240710 |
OMIM |
Surfactant Metabolism Dysfunction, Pulmonary, 2
|
| G |
Sftpc |
surfactant protein C |
|
|
ISS |
15 |
50,923,105 |
50,926,047 |
RGD:7240710 |
OMIM |
Surfactant Metabolism Dysfunction, Pulmonary, 3
|
| G |
Abca3 |
ATP-binding cassette, subfamily A (ABC1), member 3 |
|
|
ISS |
10 |
13,619,865 |
13,665,066 |
RGD:7240710 |
OMIM |
Term paths to the root
| Path 1 |
Diseases |
30711 |
 |
Respiratory Tract Diseases |
3440 |
 |
Lung Diseases |
2790 |
 |
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS |
1 |
 |
Acute Chest Syndrome |
0 |
 |
Anophthalmia with pulmonary hypoplasia |
0 |
 |
Cystic Adenomatoid Malformation of Lung, Congenital |
0 |
 |
Cystic Disease Of Lung |
0 |
 |
Cystic Fibrosis + |
108 |
 |
Hemoptysis |
0 |
 |
Hepatopulmonary Syndrome |
3 |
 |
Hypertension, Pulmonary + |
206 |
 |
Idiopathic pulmonary hemosiderosis |
0 |
 |
Kashani Strom Utley syndrome |
0 |
 |
Lung Abscess |
0 |
 |
Lung Diseases, Fungal + |
30 |
 |
Lung Diseases, Interstitial + |
249 |
 |
Lung Diseases, Obstructive + |
1067 |
 |
Lung Diseases, Parasitic + |
0 |
 |
Lung Injury + |
152 |
 |
Lung Neoplasms + |
156 |
 |
Lung agenesis |
0 |
 |
Lymphangiectasia, pulmonary, congenital |
0 |
 |
MICROPHTHALMIA, SYNDROMIC 9 |
1 |
 |
PULMONARY FUNCTION |
0 |
 |
Plasma Cell Granuloma, Pulmonary |
0 |
 |
Pneumonia + |
251 |
 |
Pulmonary Alveolar Microlithiasis |
1 |
 |
Pulmonary Alveolar Proteinosis + |
15 |
 |
Pulmonary Atelectasis + |
2 |
 |
Pulmonary Edema + |
23 |
 |
Pulmonary Embolism + |
19 |
 |
Pulmonary Emphysema + |
56 |
 |
Pulmonary Eosinophilia + |
15 |
 |
Pulmonary Fibrosis + |
154 |
 |
Pulmonary Hypoplasia, Primary |
0 |
 |
Pulmonary Veno-Occlusive Disease |
2 |
 |
Rapidly progressive glomerulonephritis with pulmonary hemorrhage |
0 |
 |
Respiratory Distress Syndrome, Adult |
60 |
 |
Respiratory Distress Syndrome, Newborn + |
24 |
 |
Scimitar Syndrome + |
0 |
 |
Solitary Pulmonary Nodule |
0 |
 |
Tetra-amelia with pulmonary hypoplasia |
0 |
 |
Tuberculosis, Pulmonary + |
70 |
 |
alpha 1-Antitrypsin Deficiency + |
1 |
 |
alpha-2-Macroglobulin Deficiency |
0 |
 |
| |
|